Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses
暂无分享，去创建一个
A. Sette | E. Daar | S. Crotty | C. Moser | J. Currier | D. Weiskopf | S. Sieg | J. Eron | A. Grifoni | F. Faraji | J. Ritz | D. Wohl | U. Parikh | S. Ramirez | P. Klekotka | David M. Smith | K. Chew | M. Hughes | Amy L Heaps